- Home
- /
- Drugs
- /
- D
- /
- Divalproex Sodium
- /
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Zydus Lifesciences Limited
Divalproex Sodium
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 American Health Packaging
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 NCS HealthCare of KY, LLC dba Vangard Labs
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Lupin Pharmaceuticals, Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Aurobindo Pharma Limited
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 BluePoint Laboratories
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Upsher-Smith Laboratories, LLC
- Depakote DIVALPROEX SODIUM 125 mg/1 AbbVie Inc.
- Depakote DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Upsher-Smith Laboratories, LLC
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 BluePoint Laboratories
- Depakote DIVALPROEX SODIUM 125 mg/1 AbbVie Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Sun Pharmaceutical Industries, Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Rising Pharma Holdings, Inc.
- Depakote DIVALPROEX SODIUM 125 mg/1 AbbVie Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Unichem Pharmaceuticals (USA), Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Zydus Lifesciences Limited
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Zydus Pharmaceuticals (USA) Inc.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 REMEDYREPACK INC.
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 A-S Medication Solutions
- Divalproex Sodium DIVALPROEX SODIUM 125 mg/1 Lupin Pharmaceuticals, Inc.
Summary of product characteristics
Effective Time
20230921
Version
9
Spl Product Data Elements
Divalproex Sodium Divalproex Sodium DIVALPROEX SODIUM VALPROIC ACID AMMONIA BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE FERROSOFERRIC OXIDE HYPROMELLOSES ISOPROPYL ALCOHOL MAGNESIUM STEARATE METHACRYLIC ACID POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TALC TRIETHYL CITRATE WHITE TO OFF WHITE OVAL ZA08 Divalproex Sodium Divalproex Sodium DIVALPROEX SODIUM VALPROIC ACID AMMONIA BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE FERROSOFERRIC OXIDE HYPROMELLOSES ISOPROPYL ALCOHOL MAGNESIUM STEARATE METHACRYLIC ACID POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TALC TRIETHYL CITRATE WHITE TO OFF-WHITE OVAL ZA07 Divalproex Sodium Divalproex Sodium DIVALPROEX SODIUM VALPROIC ACID AMMONIA BUTYL ALCOHOL CELLULOSE, MICROCRYSTALLINE FERROSOFERRIC OXIDE HYPROMELLOSES ISOPROPYL ALCOHOL MAGNESIUM STEARATE METHACRYLIC ACID POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TALC TRIETHYL CITRATE WHITE TO OFF WHITE OVAL ZA06
Application Number
ANDA077100
Brand Name
Divalproex Sodium
Generic Name
Divalproex Sodium
Product Ndc
65841-634
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-634-01 in bottle of 100 tablets Divalproex Sodium Delayed-release Tablets USP, 125 mg Rx only 100 tablets NDC 65841-635-01 in bottle of 100 tablets Divalproex Sodium Delayed-release Tablets USP, 250 mg Rx only 100 tablets NDC 65841-636-01 in bottle of 100 tablets Divalproex Sodium Delayed-release Tablets USP, 500 mg Rx only 100 tablets Divlaproex Sodium DR Tablets USP, 125 mg Divlaproex Sodium DR Tablets USP, 250 mg Divlaproex Sodium DR Tablets USP, 500 mg
Spl Medguide
SPL MEDGUIDE
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.